BMS-777607

2455-5
EUR 185.00

BMS-911543

2630-1
EUR 142.00

BMS-911543

2630-5
EUR 414.00

BMS-754807

2631-1
EUR 131.00

BMS-754807

2631-5
EUR 370.00

BMS-303141

2821-10
EUR 207.00

BMS-303141

2821-50
EUR 686.00

BMS-754807

A1185-100 100 mg
EUR 862.00
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807

A1185-25 25 mg
EUR 340.00
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807

A1185-5 5 mg
EUR 125.00
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807

A1185-5.1 10 mM (in 1mL DMSO)
EUR 154.00
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-599626

1614-1
EUR 213.00

BMS-599626

1614-5
EUR 615.00

BMS-378806

B1533-10 10 mg
EUR 305.00
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806

B1533-100 100 mg
EUR 1186.00
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806

B1533-5 5 mg
EUR 189.00
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806

B1533-5.1 10 mM (in 1mL DMSO)
EUR 235.00
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806

B1533-50 50 mg
EUR 838.00
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-626529

B1557-25
EUR 805.00

BMS-626529

B1557-5
EUR 240.00

BMS-708163

B1622-25
EUR 805.00

BMS-708163

B1622-5
EUR 240.00

BMS-582949

B1704-1
EUR 185.00

BMS-582949

B1704-5
EUR 588.00

BMS-986205

B1839-25
EUR 805.00

BMS-986205

B1839-5
EUR 240.00

BMS-536924

B1908-1
EUR 142.00

BMS-536924

B1908-5
EUR 414.00

BMS-986158

B2021-1
EUR 142.00

BMS-986158

B2021-5
EUR 414.00

BMS-794833

B2055-5
EUR 196.00

BMS-986020

B2290-25
EUR 631.00

BMS-986020

B2290-5
EUR 196.00

BMS-663068

B2299-25
EUR 756.00

BMS-663068

B2299-5
EUR 229.00

BMS-986142

B2420-1
EUR 196.00

BMS-986142

B2420-5
EUR 631.00

BMS 753

B5438-10 10 mg
EUR 350.00
Description: Ki : 2 nM for RAR? Three retinoic acid receptors (RAR?, RAR? and RAR? and three retinoid X receptors, members of the nuclear receptor (NR) superfamily, mediate the biological effects of retinoic acids upon development, cell differentiation and proliferation, and homeostasis.

BMS 753

B5438-50 50 mg
EUR 1266.00
Description: Ki : 2 nM for RAR? Three retinoic acid receptors (RAR?, RAR? and RAR? and three retinoid X receptors, members of the nuclear receptor (NR) superfamily, mediate the biological effects of retinoic acids upon development, cell differentiation and proliferation, and homeostasis.

BMS-303141

B1079-10 10 mg
EUR 148.00
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-303141

B1079-25 25 mg
EUR 247.00
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-303141

B1079-5.1 10 mM (in 1mL DMSO)
EUR 134.00
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-303141

B1079-50 50 mg
EUR 398.00
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids.

BMS-794833

B1438-10 10 mg
EUR 253.00
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833

B1438-5 5 mg
EUR 164.00
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833

B1438-5.1 10 mM (in 1mL DMSO)
EUR 177.00
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833

B1438-50 50 mg
EUR 833.00
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833

B1438-S Evaluation Sample
EUR 81.00
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-817378

B5862-10 10 mg
EUR 311.00
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-817378

B5862-5 5 mg
EUR 189.00
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-817378

B5862-50 50 mg
EUR 833.00
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-582949

B6187-1 1 mg
EUR 145.00
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-582949

B6187-25 25 mg
EUR 777.00
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-582949

B6187-5 5 mg
EUR 290.00
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-833923

9547-25
EUR 544.00

BMS-833923

9547-5
EUR 175.00

BMS-299897

9606-25
EUR 675.00

BMS-299897

9606-5
EUR 207.00

Bms 626529

20-abx182383
  • EUR 1720.00
  • EUR 620.00
  • 0
  • 1
  • Shipped within 1-2 weeks.

BMS 687453

C3544-10 10 mg
EUR 328.00
Description: IC50: 10 nM for human PPAR?BMS 687453 is a PPAR? agonist.

BMS 687453

C3544-25 25 mg
EUR 659.00
Description: IC50: 10 nM for human PPAR?BMS 687453 is a PPAR? agonist.

BMS 687453

C3544-5 5 mg
EUR 206.00
Description: IC50: 10 nM for human PPAR?BMS 687453 is a PPAR? agonist.

BMS 191011

B7146-10 10 mg
EUR 232.00
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients.

BMS 191011

B7146-25 25 mg
EUR 483.00
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients.

BMS 191011

B7146-5 5 mg
EUR 145.00
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients.

BMS 191011

B7146-50 50 mg
EUR 818.00
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients.

BMS 193885

B7327-10 10 mg
EUR 454.00
Description: BMS-193885 is a potent and selective neuropeptide Y1 receptor antagonist with IC50 of 5.9nM.Neuropeptide Y receptor 1 is G-protein coupled receptors and implicated in the modulation of food intake and energy homeostasis.

BMS 193885

B7327-50 50 mg
EUR 1714.00
Description: BMS-193885 is a potent and selective neuropeptide Y1 receptor antagonist with IC50 of 5.9nM.Neuropeptide Y receptor 1 is G-protein coupled receptors and implicated in the modulation of food intake and energy homeostasis.

BMS 453

B7396-10 10 mg
EUR 270.00
Description: BMS 453 is a synthetic RAR (retinoic acid receptor) antagonist [1]. The retinoic acid receptors (RAR?, RAR?, RAR?) belong to steroid nuclear receptor superfamily and the expressions of retinoid receptor RAR? and RAR? are correlated with the antiproliferative effects of retinoids.

BMS 453

B7396-25 25 mg
EUR 537.00
Description: BMS 453 is a synthetic RAR (retinoic acid receptor) antagonist [1]. The retinoic acid receptors (RAR?, RAR?, RAR?) belong to steroid nuclear receptor superfamily and the expressions of retinoid receptor RAR? and RAR? are correlated with the antiproliferative effects of retinoids.

BMS 453

B7396-5 5 mg
EUR 171.00
Description: BMS 453 is a synthetic RAR (retinoic acid receptor) antagonist [1]. The retinoic acid receptors (RAR?, RAR?, RAR?) belong to steroid nuclear receptor superfamily and the expressions of retinoid receptor RAR? and RAR? are correlated with the antiproliferative effects of retinoids.

BMS 961

B7397-10 10 mg
EUR 366.00
Description: BMS961 is a potent and selective retinoic acid receptor gamma (RAR?) agonist with IC50 values of 30 nM.RAR? belongs to the family of nuclear receptors which regulates transcription.

BMS 961

B7397-50 50 mg
EUR 1347.00
Description: BMS961 is a potent and selective retinoic acid receptor gamma (RAR?) agonist with IC50 values of 30 nM.RAR? belongs to the family of nuclear receptors which regulates transcription.

BMS 493

B7415-10 10 mg
EUR 293.00
Description: BMS493 is an inverse agonist of pan-retinoic acid receptors (pan-RARs). This compound has been shown to increase nuclear corepressor (NCoR) interaction with RARs.

BMS 493

B7415-25 25 mg
EUR 598.00
Description: BMS493 is an inverse agonist of pan-retinoic acid receptors (pan-RARs). This compound has been shown to increase nuclear corepressor (NCoR) interaction with RARs.

BMS 493

B7415-5 5 mg
EUR 196.00
Description: BMS493 is an inverse agonist of pan-retinoic acid receptors (pan-RARs). This compound has been shown to increase nuclear corepressor (NCoR) interaction with RARs.

BMS 195614

B7459-10 10 mg
EUR 311.00
Description: BMS 195614 is a selective RAR? antagonist [1]. It can bind to the RAR? subunit [5].

BMS 195614

B7459-5 5 mg
EUR 197.00
Description: BMS 195614 is a selective RAR? antagonist [1]. It can bind to the RAR? subunit [5].

BMS 195614

B7459-50 50 mg
EUR 1181.00
Description: BMS 195614 is a selective RAR? antagonist [1]. It can bind to the RAR? subunit [5].

BMS 309403

B7794-10 10 mg
EUR 189.00
Description: BMS309403 is specifically designed to target FABP4 with a Ki value less than 2 nM. It is a potent and selective FABP4 inhibitor.

BMS 309403

B7794-25 25 mg
EUR 351.00
Description: BMS309403 is specifically designed to target FABP4 with a Ki value less than 2 nM. It is a potent and selective FABP4 inhibitor.

BMS 309403

B7794-5 5 mg
EUR 131.00
Description: BMS309403 is specifically designed to target FABP4 with a Ki value less than 2 nM. It is a potent and selective FABP4 inhibitor.

BMS 309403

B7794-5.1 10 mM (in 1mL DMSO)
EUR 212.00
Description: BMS309403 is specifically designed to target FABP4 with a Ki value less than 2 nM. It is a potent and selective FABP4 inhibitor.

BMS-707035

A4069-10 10 mg
EUR 195.00
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035

A4069-100 100 mg
EUR 885.00
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035

A4069-5 5 mg
EUR 131.00
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035

A4069-50 50 mg
EUR 560.00
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-911543

A4152-10 10 mg
EUR 400.00
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543

A4152-25 25 mg
EUR 595.00
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543

A4152-5 5 mg
EUR 244.00
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.